Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Klapholz

Showing results (61-70 of 69) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 69 results.
Clinical and Vaccine Immunology : CVI|September 13, 2013
Exercise and sleep deprivation do not change cytokine expression levels in patients with chronic fatigue syndromeToru Nakamura, Stephan Schwander, Robert Donnelly, et al.
JACC. Cardiovascular Interventions|February 26, 2011
The STAT-MI (ST-Segment Analysis Using Wireless Technology in Acute Myocardial Infarction) trial improves outcomesMonica Sanchez-Ross, Gerard Oghlakian, James Maher, et al.
Journal of Cardiac Failure|April 30, 2015
Rationale and Design of the Left Atrial Pressure Monitoring to Optimize Heart Failure Therapy Study (LAPTOP-HF)Mathew S Maurer, Philip B Adamson, Maria Rosa Costanzo, et al.
JAMA|April 29, 2004
Effects of tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure: a randomized controlled trialMihai Gheorghiade, Wendy A Gattis, Christopher M O'Connor, et al.
Circulation|September 4, 2008
Effects of continuous aortic flow augmentation in patients with exacerbation of heart failure inadequately responsive to medical therapy: results of the Multicenter Trial of the Orqis Medical Cancion System for the Enhanced Treatment of Heart Failure Unresponsive to Medical Therapy (MOMENTUM)Barry Greenberg, Barbara Czerska, Reynolds M Delgado, et al.
Journal of Cardiac Failure|July 9, 2010
HFSA 2010 Comprehensive Heart Failure Practice Guideline, JoAnn Lindenfeld, Nancy M Albert, et al.
European Journal of Heart Failure|July 6, 2017
A Phase 2a dose-escalation study of the safety, tolerability, pharmacokinetics and haemodynamic effects of BMS-986231 in hospitalized patients with heart failure with reduced ejection fractionCristina Tita, Edward M Gilbert, Adrian B Van Bakel, et al.
Journal of the American College of Cardiology|April 20, 2004
Hospitalization for heart failure in the presence of a normal left ventricular ejection fraction: results of the New York Heart Failure RegistryMarc Klapholz, Matthew Maurer, April M Lowe, et al.
Circulation Research|November 9, 2016
PreSERVE-AMI: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Intracoronary Administration of Autologous CD34+ Cells in Patients With Left Ventricular Dysfunction Post STEMIArshed A Quyyumi, Alejandro Vasquez, Dean J Kereiakes, et al.
Pageof 7

Showing results (61-70 of 69) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 69 results.
Clinical and Vaccine Immunology : CVI|September 13, 2013
Exercise and sleep deprivation do not change cytokine expression levels in patients with chronic fatigue syndromeToru Nakamura, Stephan Schwander, Robert Donnelly, et al.
JACC. Cardiovascular Interventions|February 26, 2011
The STAT-MI (ST-Segment Analysis Using Wireless Technology in Acute Myocardial Infarction) trial improves outcomesMonica Sanchez-Ross, Gerard Oghlakian, James Maher, et al.
Journal of Cardiac Failure|April 30, 2015
Rationale and Design of the Left Atrial Pressure Monitoring to Optimize Heart Failure Therapy Study (LAPTOP-HF)Mathew S Maurer, Philip B Adamson, Maria Rosa Costanzo, et al.
JAMA|April 29, 2004
Effects of tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure: a randomized controlled trialMihai Gheorghiade, Wendy A Gattis, Christopher M O'Connor, et al.
Circulation|September 4, 2008
Effects of continuous aortic flow augmentation in patients with exacerbation of heart failure inadequately responsive to medical therapy: results of the Multicenter Trial of the Orqis Medical Cancion System for the Enhanced Treatment of Heart Failure Unresponsive to Medical Therapy (MOMENTUM)Barry Greenberg, Barbara Czerska, Reynolds M Delgado, et al.
Journal of Cardiac Failure|July 9, 2010
HFSA 2010 Comprehensive Heart Failure Practice Guideline, JoAnn Lindenfeld, Nancy M Albert, et al.
European Journal of Heart Failure|July 6, 2017
A Phase 2a dose-escalation study of the safety, tolerability, pharmacokinetics and haemodynamic effects of BMS-986231 in hospitalized patients with heart failure with reduced ejection fractionCristina Tita, Edward M Gilbert, Adrian B Van Bakel, et al.
Journal of the American College of Cardiology|April 20, 2004
Hospitalization for heart failure in the presence of a normal left ventricular ejection fraction: results of the New York Heart Failure RegistryMarc Klapholz, Matthew Maurer, April M Lowe, et al.
Circulation Research|November 9, 2016
PreSERVE-AMI: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Intracoronary Administration of Autologous CD34+ Cells in Patients With Left Ventricular Dysfunction Post STEMIArshed A Quyyumi, Alejandro Vasquez, Dean J Kereiakes, et al.
Pageof 7